TS-068081 — T
hese RAFT agents enable synt
hesis of novel polymer materials with enhanced biocompatibi
lity and tailored functiona
lity, suited for a wide range of biomedical app
lications.
Background
The growing demand for biofunctionalized polymer materials in fields such as drug delivery and diagnostics requires precise control over polymer properties. However, current reagents for Reversible Addition Fragmentation chain Transfer (RAFT) polymerization struggle with achieving the ne…